THERE have beeii maiiv refereiices in the literature implicatiiig aii altered nietabolism of proteiii-free sulphydryl compounds in the leukaemias : Contopotilas aiid Aiidersoii (1950) (Bergel et al., 1958(Bergel et al., , 1961(Bergel et al., , 1962.
Received foi-pubheation August 13, 1964 THERE have beeii maiiv refereiices in the literature implicatiiig aii altered nietabolism of proteiii-free sulphydryl compounds in the leukaemias : Contopotilas aiid Aiidersoii (1950) H.) has beeii studviiig a model eiizyme system desigiied to lower the level of cysteine in the circulatiiig free amiiio-acid pool, with a view to exploiting the elevated amiilo-acid requiremeiit of these cells in chemotherapy (Bergel et al., 1958 (Bergel et al., , 1961 (Bergel et al., , 1962 .
In the preseiit studv we have been conceriied with biochemical factors which iiiav be associated wiih the treatment-resistant phase in chronic granulocytic leuk-aeniia (CGL) . Maiiv patients in the later stages of the disease develop the -%vell-known blast-cell crisis, but it is not certaiii how far treatmeiit resistaiiee is associated with this traiisformation. Most of the leukaemic patients which form the subject-matter of this report were treated with the alkylating agent busulphail (I .4 (Roberts and Warwick, 1961a, 1961b) . Further, the respoiise of certain traiisplantable tumours in the mouse to treatineiit with an alkvlatiiig ageiit may be related to the ratio of proteiii-free thiol to proteiii-bound thiol (Calcutt and Coiinors, 1963) . We wondered, therefore. whether there might be detectable abnormalities in the levels of proteiii-free sulphydryl (SH) compouiids in the blood of those patients undergoing treatmeiit with busulphaii ; furthermore, the developing resistance to busulphaii might be reflected in chaiiges in the soluble SH levels. We were interested also in the level of proteiii-free disulphide compounds (88) in blood : hitherto there has beeii little emphasis oii the ratio of protein-free sulphydryl to proteiii-free disulphide, yet this ratio is probablv a more sensitive indication of metabolic abnormality thail gross chaiiges in SA levels. (Tomita (1961) (pH 7-3) consisting of : 2-7 ml. of m/1 tris hydroxymethylamino methane, 2-2 ml. Of NII HNO3,0-6 ml. of 0-1 % gelatin, 0.2 ml. of m/1 KC1, I ml. of 0.1 m ethylene diamine tetracetic acid, 10 ml. of deionised water, and titrating with 10-3 Msilver nitrate, using the electrode assembly recommended by Thomson and Martin (1958 (Gutcho and Lauter, 1954) . Cell or plasma preparations were deproteinised with 2 vol. of 3 % sulphosalicvlic acid or 8 0"' trichloracetic acid. In the latter case the bul-k of the precipitant was removed from the protein-free supernatant by extraction with ether. All samples were concentrated by evaporation in vacuo at 40' C. and desalted electrolytica-Ily before mixing with an equal volume Of 0-5 M N-ethyl maleimide (Gutcho and Lauter, 1.954) (in isopropanol) and applying to the papers.
RESULTS

Whole blood analysis
In Table I are listed the free and total SH levels in the whole blood of eight healthy volunteers, and in Table II the levels in the whole blood of eleven patients together with their haematologic data. Fractionated blood analysis In an attempt to discover the location of disulphide found in the whole blood of patients (CGL) such as those listed in Table II , soluble sulphydryl and disulphide determinations were carried out on fractionated blood samples. As a result of these estimations it became apparent that patients (CGL) could be classified into three groups according to the location and concentration of soluble disulphide in the blood fractions. These groups were as foHows :
(1) Untreated patients (CGL) on presentation showed the presence of soluble disulphide in the leucocyte fraction (Table IV) . The total SH content of the leucocytes was not appreciably different from that of the controls (Table III) .
(2) Patients (CGL) undergoing treatment with busulphan or radiotherapy exhibited a considerably lowered total SH level in the leucocytes, compared with untreated patients in group (1) above. Soluble disulphide was still present however (Table V) .
(3) A few patients undergoing treatment with busulphan showed the presence of soluble disulphide in the erythrocytes (Table VI) . In contrast, erythrocyte and leucocyte preparations from eleven healthy volunteer donors were free of soluble disulphide (Table III :L L t-llr. -4 00 -4 C Paper chromatoyr(tphy By means of two-dimeiisional paper chromatography, it was impossible to differentiate qualitatively between the sulphur-amino acid patterli of acid-soluble fractions from untreated leukaemic patients and those from healthv donors as controls. G lutathione was the chief sulphur-containing constitueilt preseiit. DISCUSSIONN We have iiot discovered any marked difference betweeii the total protein-free sulphydryl levels in the leucocytes of untreated leukaemic patients and those of iiormal donors. This is in agreement with the observations of Hardin et al. (1954) , though at variance with those of Contopoulas ai-id Andersoii (1950) .
A study of the data in Tables I and 11 indicates that in the peripheral blood of uiitreated patients suffering from chronic granulocytic leukaemia and the acute blast-cell transformation, an appreciable concentration of soluble disulphide was found ; in contrast, no soluble disulphide was detected in the blood of healthy doiiors, of patients with CGL in remission, of patients with polycythemia rubra vera, or chronic lymphocytic leukaemia. The occurreiice of this disulphide in the blood from a patient with CGL and its disappearance following a course of radiotherapy is strikiiigly demoiistrated in the data for patieilt A. C. (Table 11 ). The disulphide disappeared when the leukocytic proliferation was colitrolled.
In the analysis of fractionat'ed blood preparations, no attempt was made to prevent autoxidatioii of thiols in the plasma fractioii (Rony et al.. 1964), ai-id in coiisequence only the total thiol level is reported here.
Patients with CGL could be classified into three groups accordiiig to the locatioii aiid coiicentration of soluble disulphide in the blood cells. The first group (Table IV) contained untreated patieiits with high total leucocyte couiits (in the region of 50,000 to 500,000 cells per c. mm.) : proteiii-free disulphide was found in the leucocytes of all these patients (13-71 %), though the total sulphydryl titratioii was comparable to that of the controls. Thus it would appear that some of the tl-liol of the leucocyte fraction had become oxidised. Both erythrocyte aiid plasma titratioiis were comparable to those of the coiitrols. Wbere 88 determinations were carried out on the whole blood in additioii to the isolated fractions, it was found that the disulphide in the leucocvtes accouiited for iio more than approximately 20 % of the total fouiid in the whole blood. Hei-ice, soluble disulphide occurred also in the plasma of these patients.
The second group (Table V) 4. Paper chromatography of fractions from untreated CGL blood ilidicated glutathione as the main sulphur-containing constituent preseiit.
